The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Formulation of Poloxamers for Drug Delivery
Open accessAbstract
Poloxamers, also known as Pluronics®, are block copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), which have an amphiphilic character and useful association and adsorption properties emanating from this. Poloxamers find use in many applications that require solubilization or stabilization of compounds and also have notable physiological properties, including low toxicity. Accordingly, poloxamers serve well as excipients for pharmaceuticals. Current challenges facing nanomedicine revolve around the transport of typically water-insoluble drugs throughout the body, followed by targeted delivery. Judicious design of drug delivery systems leads to improved bioavailability, patient compliance and therapeutic outcomes. The rich phase behavior (micelles, hydrogels, lyotropic liquid crystals, etc.) of poloxamers makes them amenable to multiple types of processing and various product forms. In this review, we first present the general solution behavior of poloxamers, focusing on their self-assembly properties. This is followed by a discussion of how the self-assembly properties of poloxamers can be leveraged to encapsulate drugs using an array of processing techniques including direct solubilization, solvent displacement methods, emulsification and preparation of kinetically-frozen nanoparticles. Finally, we conclude with a summary and perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436 · cited 6×
“Physical properties [84] and structures [85] of compounds commonly studied for targeted d ug delivery against ailments including ancer (paclitaxel), high cholest rol (fenofibrate), arthritic pain (ibuprofen and flurbiprofen), seizures (oxcarbazepine) and vitamin deficiencies (vitamin Κ1).”
BackgroundInfluentialAlexandridis, P., & Alan Hatton, T. (1995) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/0927-7757(94)03028-x · Cited by 1,920
Self-citationAlexandridis, P., Holzwarth, J. F., & Hatton, T. A. (1994) · Macromolecules · doi:10.1021/ma00087a009 · Cited by 1,862
Self-citationInjectable hydrogels as unique biomedical materials
Yu, L., & Ding, J. (2008) · Chemical Society Reviews · doi:10.1039/b713009k · Cited by 1,545
Wanka, G., Hoffmann, H., & Ulbricht, W. (1994) · Macromolecules · doi:10.1021/ma00093a016 · Cited by 1,496
Thermosensitive sol-gel reversible hydrogels
Jeong, B., Kim, S. W., & Bae, Y. H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00242-3 · Cited by 1,478
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Future perspectives and recent advances in stimuli-responsive materials
Roy, D., Cambre, J. N., & Sumerlin, B. S. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.10.008 · Cited by 1,474
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Cited by
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Poloxamer: A versatile tri-block copolymer for biomedical applications
Zarrintaj, P., Ramsey, J. D., Samadi, A., Atoufi, Z., Yazdi, M. K., Ganjali, M. R., Amirabad, L. M., Zangene, E., Farokhi, M., Formela, K., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.028 · Cited by 404
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030159 · Cited by 368
Shriky, B., Kelly, A., Isreb, M., Babenko, M., Mahmoudi, N., Rogers, S., Shebanova, O., Snow, T., & Gough, T. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.12.096 · Cited by 299
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier
Gharbavi, M., Amani, J., Kheiri-Manjili, H., Danafar, H., & Sharafi, A. (2018) · Advances in Pharmacological Sciences · doi:10.1155/2018/6847971 · Cited by 287
Kwon, M., Lim, D. Y., Lee, C. H., Jeon, J.-H., Choi, M.-K., & Song, I.-S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090882 · Cited by 76
Ch, S., Padaga, S. G., Ghosh, B., Roy, S., & Biswas, S. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120822 · Cited by 40
RetractedKumar, S., Yadav, A., Verma, R. K., Kumar, A., Gupta, P. K., & Shukla, R. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00386 · Cited by 14
Metadata
- Authors
- Bodratti, A., & Alexandridis, P.
- Venue
- Journal of Functional Biomaterials
- Publisher
- MDPI AG
- Published
- 2018-01-18
- Volume
- 9
- Issue
- 1
- Pages
- 11
- ISSN
- 2079-4983 (ISSN-L)
- OpenAlex
- W2793276275
- Cited by
- 589
- References
- 136
- FWCI
- 23.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.